Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation

  • Authors:
    • Neng Qian
    • Xiaobo Li
    • Xinhong Wang
    • Chungen Wu
    • Lianhua Yin
    • Xiuling Zhi
  • View Affiliations / Copyright

    Affiliations: School of Basic Medicine, Shanghai University of Medicine and Health Science, Shanghai 201318, P.R. China, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China, Laboratory of Medical Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China
    Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1513-1520
    |
    Published online on: May 31, 2018
       https://doi.org/10.3892/ol.2018.8856
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Mast cells have been demonstrated to accumulate around and within solid tumors of numerous types, and express a number of pro‑angiogenic compounds, including tryptase. They may serve an early role in angiogenesis within developing tumors. In the present study, the role and mechanism of tryptase in the activation of endothelial progenitor cells (EPCs) in breast cancer angiogenesis were evaluated. Human umbilical cord blood EPCs were isolated and cultured. MB‑MDA‑231 breast cancer cells were then pretreated with tryptase, and the conditioned medium was collected. The effects of tryptase on the migratory and angiogenesis abilities of EPCs were determined using wound‑healing and tube formation assays, respectively. The effect of tryptase on the proliferation of EPCs was detected using a Cell Counting Kit‑8 assay. Alterations in proteinase activated receptor (PAR)‑2, phosphorylated (p)‑protein kinase B (AKT), p‑extracellular signal‑regulated kinase (p‑ERK) and vascular endothelial growth factor receptor (VEGFR)‑2 expression were analyzed, in tryptase or conditioned medium‑treated EPCs, by western blot analysis and reverse transcription‑quantitative polymerase chain reaction. It was confirmed that the EPCs expressed PAR‑2; and that tryptase treatment promoted the migration and tube formation of EPCs. Treatment with a PAR‑2 agonist had a similar effect to tryptase, whereas treatment with a tryptase inhibitor, APC366, or a PAR‑2 inhibitor, SAM 11, inhibited the effect of tryptase treatment. Tryptase and PAR‑2 agonists did not affect the rate of EPC proliferation. MB‑MDA‑231 cells also expressed PAR‑2. Treatment with tryptase or conditioned medium increased the expression of PAR‑2, p‑AKT, p‑ERK and VEGFR‑2 in EPCs. In conclusion, tryptase activated EPCs via PAR‑2‑mediated AKT and ERK signaling pathway activation, thereby enhancing angiogenesis in breast cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Folkman J: Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res. 312:594–607. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Roberts N, Jahangiri M and Xu Q: Progenitor cells in vascular disease. J Cell Mol Med. 9:583–591. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S and Sirigu P: Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 33:420–425. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Ribatti D, Finato N, Crivellato E, Guidolin D, Longo V, Mangieri D, Nico B, Vacca A and Beltrami CA: Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology. 51:837–842. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Mauro LV, Bellido M, Morandi A, Bonadeo F, Vaccaro C, Quintana GO, Pallotta MG, Lastiri J, Puricelli LI and de Cidre LL: Association between mast cells of different phenotypes and angiogenesis in colorectal cancer. Mol Med Rep. 1:895–902. 2008.PubMed/NCBI

6 

Micu GV, Stăniceanu F, Sticlaru LC, Popp CG, Bastian AE, Gramada E, Pop G, Mateescu RB, Rimba M, Archip B and Bleotu C: correlations between the density of tryptase positive mast cells (DMCT) and that of new blood vessels (CD105+) in patients with gastric cancer. Rom J Intern Med. 54:113–120. 2016.PubMed/NCBI

7 

Norrby K: Mast cells and angiogenesis. APMIS. 110:355–371. 2002. View Article : Google Scholar : PubMed/NCBI

8 

He S and Walls AF: Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol. 328:89–97. 1997. View Article : Google Scholar : PubMed/NCBI

9 

He S, Peng Q and Walls AF: Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine. J Immunol. 159:6216–6225. 1997.PubMed/NCBI

10 

Cairns JA and Walls AF: Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol. 156:275–283. 1996.PubMed/NCBI

11 

Xiang M, Gu Y, Zhao F, Lu H, Chen S and Yin L: Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep. 23:615–619. 2010.PubMed/NCBI

12 

Ossovskaya VS and Bunnett NW: Protease-activated receptors: Contribution to physiology and disease. Physiol Rev. 84:579–621. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Yau MK, Liu L and Fairlie DP: Toward drugs for protease-activated receptor 2 (PAR2). J Med Chem. 56:7477–7497. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Jahan I, Fujimoto J, Alam SM, Sato E, Sakaguchi H and Tamaya T: Role of protease activated receptor-2 in tumor advancement of ovarian cancers. Ann Oncol. 18:1506–1512. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Darmoul D, Gratio V, Devaud H and Laburthe M: Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem. 279:20927–20934. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Liu Y and Mueller BM: Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun. 344:1263–1270. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Smadja DM, Bièche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C, Vidaud M, Aiach M and Gaussem P: PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol. 25:2321–2327. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Ranieri G, Ammendola M, Patruno R, Celano G, Zito FA, Montemurro S, Rella A, Di Lecce V, Gadaleta CD, Battista De Sarro G and Ribatti D: Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol. 35:115–120. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM, Waltenberger J and Beltinger C: Endothelial progenitor cell culture and differentiation in vitro: A methodological comparison using human umbilical cord blood. Cardiovasc Res. 58:478–486. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Liang CC, Park AY and Guan JL: In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Arnaoutova I, George J, Kleinman HK and Benton G: The endothelial cell tube formation assay on basement membrane turns 20: State of the science and the art. Angiogenesis. 12:267–274. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D and Hatzopoulos AK: Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med. 197:1755–1765. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G and Bertolini F: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood. 97:3658–3661. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K and Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 319:195–198. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P and Young PP: VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 20:1495–1497. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Starkey JR, Crowle PK and Taubenberger S: Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer. 42:48–52. 1988. View Article : Google Scholar : PubMed/NCBI

28 

Caughey GH: Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev. 217:141–154. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Marech I, Ammendola M, Sacco R, Capriuolo GS, Patruno R, Rubini R, Luposella M, Zuccalà V, Savino E, Gadaleta CD, et al: Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: Possible translational significance. BMC Cancer. 14:5342014. View Article : Google Scholar : PubMed/NCBI

30 

Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG and Gruber BL: Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 99:2691–2700. 1997.

31 

Hiromatsu Y and Toda S: Mast cells and angiogenesis. Microsc Res Tech. 60:64–69. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Kawabata A: Gastrointestinal functions of proteinase-activated receptors. Life Sci. 74:247–254. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Ammendola M, Leporini C, Marech I, Gadaleta CD, Scognamillo G, Sacco R, Sammarco G, de Sarro G, Russo E and Ranieri G: Targeting mast cells tryptase in tumor microenvironment: A potential antiangiogenetic strategy. Biomed Res Int. 2014:1547022014. View Article : Google Scholar : PubMed/NCBI

34 

Ge L, Shenoy SK, Lefkowitz RJ and DeFea K: Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and −2. J Biol Chem. 279:55419–55424. 2004. View Article : Google Scholar : PubMed/NCBI

35 

Wilson SR, Gallagher S, Warpeha K and Hawthorne SJ: Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate. 60:168–174. 2004. View Article : Google Scholar : PubMed/NCBI

36 

Ma Y, Zhang B, Qian R, Lu C, Zhao F and Yin L: Tryptase activates PKB in inflammatory reaction in ECV304 cells. Biochim Biophys Acta. 1763:313–321. 2006. View Article : Google Scholar : PubMed/NCBI

37 

Nonaka M, Pawankar R, Fukumoto A, Ogihara N, Sakanushi A and Yagi T: Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Clin Exp Allergy. 34:804–811. 2004. View Article : Google Scholar : PubMed/NCBI

38 

Kohri K, Ueki IF and Nadel JA: Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol. 283:L531–L540. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Compton SJ, McGuire JJ, Saifeddine M and Hollenberg MD: Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. Can J Physiol Pharmacol. 80:987–992. 2002. View Article : Google Scholar : PubMed/NCBI

40 

Koo BH, Chung KH, Hwang KC and Kim DS: Factor Xa induces mitogenesis of coronary artery smooth muscle cell via activation of PAR-2. FEBS Lett. 523:85–89. 2002. View Article : Google Scholar : PubMed/NCBI

41 

Yoshii M, Jikuhara A, Mori S, Iwagaki H, Takahashi HK, Nishibori M and Tanaka N: Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J Pharmacol Sci. 98:450–458. 2005. View Article : Google Scholar : PubMed/NCBI

42 

Weidinger S, Mayerhofer A, Kunz L, Albrecht M, Sbornik M, Wunn E, Hollweck R, Ring J and Kohn FM: Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway. Hum Reprod. 20:456–461. 2005. View Article : Google Scholar : PubMed/NCBI

43 

Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, et al: PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin Cancer Res. 19:2342–2354. 2013. View Article : Google Scholar : PubMed/NCBI

44 

Wang JY, Lee YT, Chang PF and Chau LY: Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK. J Cell Physiol. 219:617–625. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qian N, Li X, Wang X, Wu C, Yin L and Zhi X: Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation. Oncol Lett 16: 1513-1520, 2018.
APA
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., & Zhi, X. (2018). Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation. Oncology Letters, 16, 1513-1520. https://doi.org/10.3892/ol.2018.8856
MLA
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., Zhi, X."Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation". Oncology Letters 16.2 (2018): 1513-1520.
Chicago
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., Zhi, X."Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation". Oncology Letters 16, no. 2 (2018): 1513-1520. https://doi.org/10.3892/ol.2018.8856
Copy and paste a formatted citation
x
Spandidos Publications style
Qian N, Li X, Wang X, Wu C, Yin L and Zhi X: Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation. Oncol Lett 16: 1513-1520, 2018.
APA
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., & Zhi, X. (2018). Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation. Oncology Letters, 16, 1513-1520. https://doi.org/10.3892/ol.2018.8856
MLA
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., Zhi, X."Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation". Oncology Letters 16.2 (2018): 1513-1520.
Chicago
Qian, N., Li, X., Wang, X., Wu, C., Yin, L., Zhi, X."Tryptase promotes breast cancer angiogenesis through PAR‑2 mediated endothelial progenitor cell activation". Oncology Letters 16, no. 2 (2018): 1513-1520. https://doi.org/10.3892/ol.2018.8856
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team